PicS NV
PICS
5.02
+0.17
+3.51%
PicS NV
US · PICS
#2995 by market cap
Listed 2026
5.02
+0.17
+3.51%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
RBC Capital Sticks to Their Buy Rating for PicS N.V. Class A (PICS)TipRanks · 2026/8/31
-
Company notice
JBCC Holdings: JBBC and Hitachi Solutions East Japan have launched a joint service that integrates the production management system "R-PiCS NX" with "scSQUARE ISP."JPX · 2026/8/6
-
Company notice
ULURU Co Ltd: "Pod pics" officially starts, and the work can be entrusted in the staff's "where they are now" to confirm the results in real time.JPX · 2018/3/5
-
Rating change
RBC Capital Maintains PicS NV(PICS.US) With Buy Rating, Cuts Target Price to $19Market Newswire · 2026/4/4
-
Rating change
Banco Bradesco BBI S.A Initiates Coverage On PicS With Outperform Rating, Announces Price Target of $21Benzinga · 2026/4/7
-
Rating change
Wolfe Research Maintains PicS NV(PICS.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/6/15
-
Rating change
Mizuho Securities Maintains PicS NV(PICS.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/6/4
-
Rating change
BofA Securities Maintains PicS NV(PICS.US) With Buy RatingMarket Newswire · 2026/6/23
-
Rating change
Analysts Offer Insights on Technology Companies: Verisign (VRSN) and PicS N.V. Class A (PICS)TipRanks · 2026/4/4
-
RBC Capital Maintains PicS NV(PICS.US) With Buy Rating, Cuts Target Price to $16Market Newswire · 2026/8/25
-
Rating change
Analysts' Top Technology Picks: PicS N.V. Class A (PICS), Cognyte Software (CGNT)TipRanks · 2026/6/3
-
Company notice
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on its subsidiary obtaining PIC/S GMP certificationSZSI · 2025/12/31
-
Mizuho Securities Maintains PicS NV(PICS.US) With Buy Rating, Cuts Target Price to $16Market Newswire · 2026/8/26
-
BofA Securities Maintains PicS NV(PICS.US) With Buy Rating, Maintains Target Price $27Market Newswire · 2026/8/25
-
Rating change
RBC Capital Maintains PicS NV(PICS.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/6/3
-
Rating change
Wolfe Research Initiates PicS NV(PICS.US) With Buy Rating, Announces Target Price $15Market Newswire · 2026/6/3
-
Company notice
Health Source: Announcement of Health Source Pharmaceutical Group Co., Ltd. on its subsidiary obtaining PIC/S GMP certificationSZSI · 2025/12/31
-
Analysts Offer Insights on NA Companies: NS Solutions (OtherNSSXF) and PicS N.V. Class A (PICS)TipRanks · 2026/8/25
-
Rating change
RBC Capital Maintains PicS NV(PICS.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/4/6
-
Rating change
PicS Initiated at Outperform by Banco Bradesco BBI S.ADow Jones · 2026/4/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
PicS NV discussion 0 comments